ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1647

Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study

Lien Moreel1, Walter Coudyzer2, Lennert Boeckxstaens3, Albrecht Betrains1, Geert Molenberghs4, Steven Vanderschueren1, Eveline Claus2, Koen Van Laere5 and Daniel Blockmans1, 1Department of General Internal Medicine, University Hospitals Leuven, Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium, 2Department of Radiology, University Hospitals Leuven, Leuven, Belgium, 3Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium, 4Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), University of Leuven and Hasselt University, Leuven, Belgium, 5Department of Nuclear Medicine, University Hospitals Leuven,Department of Imaging and Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium

Meeting: ACR Convergence 2023

Keywords: giant cell arteritis, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Imaging

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Patients with giant cell arteritis (GCA) have an increased risk of developing thoracic aortic aneurysms. Retrospective studies have shown that 18F-fluorodeoxyglucose (FDG) uptake in large vessels at diagnosis increases the risk of developing aortic complications during follow-up. The aim of this study was to prospectively evaluate the association between FDG uptake in large vessels at diagnosis and the evolution of aortic diameter and volume in GCA patients.

Methods: GCA patients who have had FDG positron emission tomography (PET) imaging at diagnosis ≤3 days after initiation of glucocorticoids and who were prospectively followed for ≥2 years were included. PET scans were semi quantitatively scored (0-3) at 7 vascular areas and a total vascular score (TVS) was calculated, ranging from 0 to 21. PET scans were considered positive in case of FDG uptake ≥ grade 2 in any large vessel. Patients underwent computed tomography (CT) imaging at diagnosis and yearly thereafter for a maximum of 10 years. The association between vascular FDG uptake and aortic dimensions was estimated by linear mixed effect models with random intercept and slope in time adjusted for age, sex, AORTA score, CT or PET/CT scan and intravenous contrast. The ascending aorta, aortic arch, and descending aorta were considered aneurysmatic when the diameter was ≥45, ≥40, and ≥35 mm, respectively.

Results: Hundred patients (mean age 70 years, 68% females) were included, of which 74 (74%) had FDG uptake ≥ grade 2 in any large vessel. The 2022 ACR/EULAR GCA criteria were fulfilled in 89 (89%) patients. Median follow-up was 80 months (IQR 47-110). The increase in ascending and descending aortic diameter and in thoracic aortic volume was higher in patients with a positive PET scan compared to those without (difference in 5-year progression 1.53 mm [95%CI 0.36-2.70 mm], 1.22 mm [95%CI 0.28-2.16 mm] and 20.29 cm³ [95%CI 4.07-36.57 cm³], respectively) (Table 1). These thoracic aortic dimensions were also significantly associated with TVS (Figure 1). FDG uptake was not associated with an increase in abdominal aortic diameters nor volume. Patients with a positive PET scan had a higher risk of developing thoracic aortic aneurysms (aHR 13.61, 95%CI 1.63-113.50) with a median time since diagnosis of 40 months (IQR 18-61). Thoracic aortic aneurysm developed in 13 of the 15 (87%) patients in a region with elevated FDG uptake at diagnosis. Two patients with high TVS (15 and 16) needed surgery for ascending aortic aneurysm.

Conclusion: Higher TVS was associated with greater yearly increase in thoracic aortic dimensions. Vascular FDG uptake at diagnosis was an independent risk factor for developing thoracic aortic aneurysm in GCA patients. Performing PET imaging at diagnosis may help to estimate the future risk of aortic aneurysm formation. Follow-up of aortic dimensions may be warranted in patients with thoracic aortic FDG uptake or high TVS.

Supporting image 1

Table 1: Evolution of the aortic diameters (in mm) and volumes (in cm³) in 5 years in patients with (PET positive) and without (PET negative) FDG uptake ≥ grade 2 in any large vessel. The linear mixed models were adjusted for age, sex, AORTA score, CT or PET/CT scan, and intravenous contrast.
Abbreviations: 95% CI, 95% confidence interval; CT, computed tomography; FDG, fluorodeoxyglucose; PET, positron emission tomography

Supporting image 2

Figure 1: Linear mixed model analysis of the association between the total vascular score and the evolution in aortic dimensions.
The x-axis represents the time (in years) since the diagnosis. The y-axis represents the size of the aorta: A. volume of thoracic aorta (in cm³), B. diameter of ascending aorta (in mm), C. diameter of aortic arch (in mm), D. diameter of descending aorta (in mm), E. volume of abdominal aorta (in cm³), F. diameter of suprarenal aorta (in mm), G. diameter of juxtarenal aorta (in mm), and H. diameter of infrarenal aorta (in mm). The lines and bands represent the mean trajectory and 95% confidence interval of each subgroup. The red solid line represents the first quartile of the total vascular score, the blue dotted line the median and the green dashed line the third quartile. The linear mixed models were adjusted for age, sex, AORTA score, CT or PET/CT scan, and intravenous contrast.
Abbreviations: CT, computed tomography; PET, positron emission tomography; TVS, total vascular score


Disclosures: L. Moreel: None; W. Coudyzer: None; L. Boeckxstaens: None; A. Betrains: None; G. Molenberghs: None; S. Vanderschueren: None; E. Claus: None; K. Van Laere: None; D. Blockmans: None.

To cite this abstract in AMA style:

Moreel L, Coudyzer W, Boeckxstaens L, Betrains A, Molenberghs G, Vanderschueren S, Claus E, Van Laere K, Blockmans D. Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/association-between-vascular-fdg-uptake-at-diagnosis-and-evolution-in-aortic-dimensions-in-giant-cell-arteritis-a-prospective-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-vascular-fdg-uptake-at-diagnosis-and-evolution-in-aortic-dimensions-in-giant-cell-arteritis-a-prospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology